← Back to Search

Behavioral Intervention

Telemedicine based CBT-I for Insomnia

N/A
Waitlist Available
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up administered at baseline, at the end of receiving cbt-i (~6 weeks), at 2 weeks following treatment, and at 12 weeks following treatment
Awards & highlights
No Placebo-Only Group

Summary

Insomnia is a common medical condition that has a deleterious effect on emotional status, health-related quality of life, and has been associated with hospitalizations and all-cause mortality. Recently hospitalized patients who are recuperating in their homes would find it difficult to return for weekly visits with a clinical psychologist and therefore could benefit from the convenience of CBT-I treatment administered in the comfort of their homes via the wireless iPAD and video chat software. In patients who are recently discharged from the hospital, we wish to assess whether telemedicine-based CBT-I is comparable to conventional office-based CBT-I in the efficacy for treating insomnia. Research aiming to improve understanding of whether insomnia represents a modifiable risk factor for re-hospitalizations in patients who are high utilizers of healthcare services is an important area of future research.

Eligible Conditions
  • Insomnia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~administered at baseline, at the end of receiving cbt-i (~6 weeks), at 2 weeks following treatment, and at 12 weeks following treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and administered at baseline, at the end of receiving cbt-i (~6 weeks), at 2 weeks following treatment, and at 12 weeks following treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Insomnia Severity Index (ISI)
Secondary study objectives
Consumer Assessment of Health Plans Survey (CAHPS v4.0) item
Other study objectives
Epworth Sleepiness Scale (ESS)
Healthcare utilization
Pittsburgh Sleep Quality Index (PSQI)
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Telemedicine based CBT-IExperimental Treatment1 Intervention
The treatment will be the exact same as the active comparator group, with the same clinical psychologist doing the office-based CBT-I, but will be administered through a telemedicine modality
Group II: Conventional office-based CBT-IActive Control1 Intervention
CBT-I will be delivered by a licensed clinical psychologist in weekly sessions lasting up to 1 hour. There will be 6 CBT-I sessions over the course of therapy with the option of an additional 2 treatments if deemed necessary by the clinical psychologist.

Find a Location

Who is running the clinical trial?

American Academy of Sleep MedicineOTHER
24 Previous Clinical Trials
2,756 Total Patients Enrolled
4 Trials studying Insomnia
306 Patients Enrolled for Insomnia
University of ArizonaLead Sponsor
534 Previous Clinical Trials
159,401 Total Patients Enrolled
5 Trials studying Insomnia
298 Patients Enrolled for Insomnia
~9 spots leftby Nov 2025